Moyes; Christopher Richard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moyes; Christopher Richard.The latest application filed is for "2,3-substituted fused pyrimidin -4 (3h)-ones as vr1 antagonists".

Company Profile

0.7.5

Moyes; Christopher Richard - Westfield NJ
Moyes; Christopher Richard - Hertford GB
Moyes; Christopher Richard -
Moyes; Christopher Richard - Harlow GB
Moyes; Christopher Richard - Sawbridgeworth GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists App 20110152242 - Bayliss; Tracy ; et al.	2011-06-23
Amino-heterocycles as VR-1 antagonists for treating pain Grant 7,442,701 - Blurton , et al. October 28, 2	2008-10-28
Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain Grant 7,285,563 - Brown , et al. October 23, 2	2007-10-23
Amino-heterocycles as vr-1 antagonists for treating pain App 20060040947 - Blurton; Peter ; et al.	2006-02-23
Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain App 20050197342 - Hollingworth, Gregory John ; et al.	2005-09-08
Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain App 20050107388 - Brown, Rebecca Elizabeth ; et al.	2005-05-19
Imidazo-triazine derivatives as ligands for GABA receptors Grant 6,608,062 - Carling , et al. August 19, 2	2003-08-19
Phenylindole derivatives as 5-ht2a receptor ligands Grant 6,479,480 - Moyes , et al. November 12, 2	2002-11-12
Substituted 1H-pyridinyl-2-ones as GABAA alpha 2/3 ligands Grant 6,352,994 - Collins , et al. March 5, 2	2002-03-05
Substituted 1H-pyridinyl-2-ones as GABAA alpha 2/3 ligands App 20010018438 - Collins, Ian James ; et al.	2001-08-30
Substituted 1H-pyridinyl-2-ones as GABAA-.alpha. 2/3 ligands Grant 6,200,982 - Collins , et al. March 13, 2	2001-03-13
Tricyclic pyridone analogues as GABA-A receptor ligands Grant 6,133,255 - Harrison , et al. October 17, 2	2000-10-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.